This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,253.17, is for the delivery of Lamictal XR 25 mg tablets, a prescription medication used to treat epilepsy and bipolar disorder. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,470.18 firm fixed-price delivery order is for the supply of Lamictal XR 200 mg tablets, a medication used to treat epilepsy and certain types of mental health conditions. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,531.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamictal XR 50 mg tablets, a prescription medication used to treat certain types of seizures and bipolar disorder. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LAMICTAL XR 250 MG TABLET 30S. The $13,637.86 firm fixed price contract has an ultimate completion date of October 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The $3,695.24 firm-fixed-price contract has an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The firm-fixed-price contract has a ceiling value of $5,814.13 and a completion date of June 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,038.01, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Lamictal XR 200 mg tablets. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,539.31, is for the delivery of Lamictal XR 300 mg tablets to support defense and civilian medical programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,832.65, is for the provision of LAMICTAL XR 300 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of December 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...